# Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer

> **NCT00477386** · PHASE1,PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 28 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** decitabine

## Key facts

- **NCT ID:** NCT00477386
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2011-05
- **Final completion:** 2013-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477386, "Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00477386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*